CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Study of Halichondrin B Analog E7389 in Combination With Gemcitabine in Patients With Refractory or Advanced Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00410553
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:08.347162+00:00
Published At: 2018-10-03T00:00:00+00:00
Record Updated At: 2018-10-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adult Solid Neoplasm", "Recurrent Ovarian Carcinoma", "Recurrent Uterine Corpus Carcinoma", "Stage III Ovarian Cancer AJCC v6 and v7", "Stage III Uterine Corpus Cancer AJCC v7", "Stage IV Ovarian Cancer AJCC v6 and v7", "Stage IV Uterine Corpus Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-10-03"
protocolSection.identificationModule.nctId: "NCT00410553"
protocolSection.identificationModule.officialTitle: "A Phase I Study of Halichondrin B Analog E7389 in Combination With Gemcitabine in Patients With Refractory or Advanced Solid Tumors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.